Poole Sandra 4
4 · Travere Therapeutics, Inc. · Filed May 18, 2021
Insider Transaction Report
Form 4
Poole Sandra
Director
Transactions
- Award
Stock option (right to buy)
2021-05-14+9,000→ 9,000 totalExercise: $18.27From: 2022-05-14Exp: 2031-05-13→ Common Stock (9,000 underlying) - Award
Common Stock
2021-05-14+3,000→ 9,500 total
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.